Optimal initial relative dose intensity of modified FOLFIRINOX in pancreatic ductal adenocarcinoma: A retrospective multi-center cohort. - Ho IW; Li CP; Yang SH; Wang HT; Lin CY; Su YY; Ho CL; Chou WC; Chiu TJ; Shih YH; Feng YH; Chang YS; et al. (Journal of the Formosan Medical Association = Taiwan yi zhi, 2026)